To determine the significance of NTS signaling in the pathogenesis of MASLD in humans, we compared NTSR (NTSR1, NTSR2 and NTSR3) expression in liver samples from patients with MASLD and MASH with normal livers (patient characteristics are shown in Table 1). This evidence concerns the gene NTS and metabolic dysfunction-associated steatotic liver disease.